Eli Lilly (Mexico) Market Value

LLY Stock  MXN 16,063  5.95  0.04%   
Eli Lilly's market value is the price at which a share of Eli Lilly trades on a public exchange. It measures the collective expectations of Eli Lilly and investors about its performance. Eli Lilly is trading at 16063.00 as of the 25th of December 2024; that is 0.04% up since the beginning of the trading day. The stock's open price was 16057.05.
With this module, you can estimate the performance of a buy and hold strategy of Eli Lilly and and determine expected loss or profit from investing in Eli Lilly over a given investment horizon. Check out Eli Lilly Correlation, Eli Lilly Volatility and Eli Lilly Alpha and Beta module to complement your research on Eli Lilly.
Symbol

Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Eli Lilly 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eli Lilly's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eli Lilly.
0.00
11/25/2024
No Change 0.00  0.0 
In 30 days
12/25/2024
0.00
If you would invest  0.00  in Eli Lilly on November 25, 2024 and sell it all today you would earn a total of 0.00 from holding Eli Lilly and or generate 0.0% return on investment in Eli Lilly over 30 days. Eli Lilly is related to or competes with Ameriprise Financial, CVS Health, Southwest Airlines, Genworth Financial, Grupo Sports, Martin Marietta, and Grupo Hotelero. Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide More

Eli Lilly Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eli Lilly's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eli Lilly and upside and downside potential and time the market with a certain degree of confidence.

Eli Lilly Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Eli Lilly's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eli Lilly's standard deviation. In reality, there are many statistical measures that can use Eli Lilly historical prices to predict the future Eli Lilly's volatility.
Hype
Prediction
LowEstimatedHigh
16,06116,06316,065
Details
Intrinsic
Valuation
LowRealHigh
14,61514,61717,669
Details

Eli Lilly Backtested Returns

Eli Lilly secures Sharpe Ratio (or Efficiency) of -0.0546, which denotes the company had a -0.0546% return per unit of risk over the last 3 months. Eli Lilly and exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eli Lilly's Variance of 5.9, mean deviation of 1.63, and Standard Deviation of 2.43 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.36, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Eli Lilly are expected to decrease at a much lower rate. During the bear market, Eli Lilly is likely to outperform the market. At this point, Eli Lilly has a negative expected return of -0.14%. Please make sure to confirm Eli Lilly's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Eli Lilly performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.4  

Poor reverse predictability

Eli Lilly and has poor reverse predictability. Overlapping area represents the amount of predictability between Eli Lilly time series from 25th of November 2024 to 10th of December 2024 and 10th of December 2024 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eli Lilly price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Eli Lilly price fluctuation can be explain by its past prices.
Correlation Coefficient-0.4
Spearman Rank Test0.09
Residual Average0.0
Price Variance65.6 K

Eli Lilly lagged returns against current returns

Autocorrelation, which is Eli Lilly stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eli Lilly's stock expected returns. We can calculate the autocorrelation of Eli Lilly returns to help us make a trade decision. For example, suppose you find that Eli Lilly has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Eli Lilly regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eli Lilly stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eli Lilly stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eli Lilly stock over time.
   Current vs Lagged Prices   
       Timeline  

Eli Lilly Lagged Returns

When evaluating Eli Lilly's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eli Lilly stock have on its future price. Eli Lilly autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eli Lilly autocorrelation shows the relationship between Eli Lilly stock current value and its past values and can show if there is a momentum factor associated with investing in Eli Lilly and.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.